Compile Data Set for Download or QSAR
Found 18 Enz. Inhib. hit(s) with all data for entry = 50017115
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177653(5-allyl-6-chloro-2-(2,3-dihydro-1H-inden-5-ylamino...)copy SMILEScopy InChI
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177648(2-(2,3-dihydro-1H-inden-5-ylamino)-6-hydroxy-5-(3-...)copy SMILEScopy InChI
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177644(2-(2,3-dihydro-1H-inden-5-ylamino)-6-hydroxy-5-(3-...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177654(4-(3-(2-(2,3-dihydro-1H-inden-5-ylamino)-4-hydroxy...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177645(2-(2,3-dihydro-1H-inden-5-ylamino)-6-hydroxy-5-(3-...)copy SMILEScopy InChI
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177651(5-benzyl-2-(3-ethyl-4-methylphenylamino)-6-hydroxy...)copy SMILEScopy InChI
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177657(2-(2,3-dihydro-1H-inden-5-ylamino)-6-hydroxy-5-(3-...)copy SMILEScopy InChI
Affinity DataIC50: 5.10E+3nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177647(4-(3-(2-(2,3-dihydro-1H-inden-5-ylamino)-4-hydroxy...)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177665(5-allyl-2-(3-ethyl-4-methylphenylamino)-6-hydroxyp...)copy SMILEScopy InChI
Affinity DataIC50: 7.70E+3nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177656(5-(3-(4-aminophenoxy)propyl)-2-(2,3-dihydro-1H-ind...)copy SMILEScopy InChI
Affinity DataIC50: 9.00E+3nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177660(2-(2,3-dihydro-1H-inden-5-ylamino)-6-hydroxy-5-(3-...)copy SMILEScopy InChI
Affinity DataIC50: 1.16E+4nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177652(2-(2,3-dihydro-1H-inden-5-ylamino)-6-hydroxy-5-(4-...)copy SMILEScopy InChI
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177646(5-(but-3-enyl)-2-(2,3-dihydro-1H-inden-5-ylamino)-...)copy SMILEScopy InChI
Affinity DataIC50: 1.79E+4nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177663(2-(2,3-dihydro-1H-inden-5-ylamino)-6-hydroxy-5-phe...)copy SMILEScopy InChI
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177659(5-allyl-2-(2,3-dihydro-1H-inden-5-ylamino)-6-hydro...)copy SMILEScopy InChI
Affinity DataIC50: 3.10E+4nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177655(5-benzyl-2-(2,3-dihydro-1H-inden-5-ylamino)-6-hydr...)copy SMILEScopy InChI
Affinity DataIC50: 3.70E+4nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177658(6-amino-2-(3-ethyl-4-methylphenylamino)pyrimidin-4...)copy SMILEScopy InChI
Affinity DataIC50: 1.04E+5nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed
TargetDNA polymerase III PolC-type(Staphylococcus aureus)
Targanta Therapeutics Inc.

Curated by ChEMBL
LigandPNGBDBM50177649(5-allyl-6-amino-2-(3-ethyl-4-methylphenylamino)pyr...)copy SMILEScopy InChI
Affinity DataIC50: 1.64E+5nMAssay Description:Inhibition of DNA polymerase3C from Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125S75PubMed